Company profile

CellaVision AB

CellaVision AB has 5 AI-enabled medical devices on the FDA list. The first decision was on March 15, 2001 and the most recent on October 16, 2020 (CellaVision DC-1, CellaVision DC-1 PPA). Its most common review panel is Hematology (5 devices).

5AI devices

2001First decision

2020Latest decision

1Specialties

Per year

20012004200820112020

CellaVision AB AI devices per year: 2001 1, 2004 1, 2008 1, 2011 1, 2020 1

By specialty

Hematology5

Related guides

Top hematology devices

Timeline

October 16, 2020 · 510(k) K200595CellaVision DC-1, CellaVision DC-1 PPA · Hematology · JOY
September 16, 2011 · 510(k) K102778CELLAVISION DM1200 WITH THE BODY FLUID APPLICTION · Hematology · JOY
December 5, 2008 · 510(k) K080595CELLAVISION DM96 WITH THE BODY FLUID APPLICATION · Hematology · JOY
February 10, 2004 · 510(k) K033840CELLAVISION DM96 AUTOMATIC HEMATOLOGY ANALYZER · Hematology · JOY
March 15, 2001 · 510(k) K003301DIFFMASTER OCTAVIA AUTOMATIC HEMATOLOGY ANALYZER · Hematology · JOY